Enter your login e-mail to the account
Search
Search parameters
Search results
- Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - New possibilities in the pharmacotherapy of primary hypertension
MUDr. Viera Smetanová, PhD.
(2/2010, Review articles ) - Nonsteroidal anti-inflammatory drugs, anticoagulation, antiplatelet medications, changes gastric and duodenal mucosa
prof. MUDr. Petr Dítě, DrSc., MUDr. Ivo Novotný, prof. MUDr. Miroslav Penka, CSc.
(2/2010, Review articles ) - Prehľad aktuálnych európskych (ESH/ESC 2003) a amerických (JNC 7) odporúčaní pre liečbu hypertenzie
MUDr. Jozef Bulas, CSc.
(3/2004, Topic ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Kardiologický pacient z pohľadu urológa
Doc. MUDr. Jozef Marenčák, PhD.
(2/2018, Review articles ) - Advances in pharmacotherapy of pain
MUDr. Marek Hakl, Ph.D.
(5/2015, Review articles ) - Ticagrelor – a new reversible inhibitor of P2Y12 receptor in the treatment of acute coronary syndromes
prof. MUDr. Vasiľ Hricák, CSc., FESC
(3–4/2013, Drugs & drug classes ) - Klinická hypertenziológia v roku 2015. Nové pohľady, trendy, výsledky recentných štúdií Kongres Európskej kardiologickej spoločnosti 2015, Londýn, Veľká Británia, 28. augusta – 2. septembra 2015
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(5/2015, Events ) - Anticoagulant therapy in patients with atrial fibrillation
Doc. MUDr. Ján Kmec, PhD., MPH
(2/2017, Review articles ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - New possibilities of VTE prophylaxis and treatment for the knee and hip arthroplasty in orthopedic surgery
prof. MUDr. Peter Kubisz, DrSc., MUDr. Daniela Kotuličová, MUDr. Ján Staško, PhD.
(7-8/2009, Review articles ) - THERAPY OF DIABETES MELLITUS TYPE 2
MUDr. Juraj Vozár, CSc.
(1/2005, Topic ) - Pán doktor, príďte! Zápisky lekára po 100 rokoch
MUDr. Jozef Jakuš
(4/2005, Relax ) - MANAGEMENT OF PATIENTS AFTER CORONARY REVASCULARISATION PROCEDURES: GENERAL PRACTITIONER`S
prof. MUDr. Vasiľ Hricák, PhD., MFSC.
(4/2005, Topic ) - COXIBS IN RHEUMATOLOGY
doc. MUDr. Jozef Lukáč, CSc., prof. MUDr. Jozef Rovenský, DrSc., MUDr. Oľga Lukáčová, PhD.
(2/2005, Topic ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - TREATMENT OF ACUTE CORONARY SYNDROME WITHOUT PERSISTENT ELEVATION OF ST-SEGMENT IN ELECTROCARDIOGRAPHIC IMAGE
MUDr. Jaroslav Sumbal
(5/2007, Topic ) - PREVENTION OF THE ISCHEMIC HEART DISEASE
MUDr. Milan Luknár, MUDr. Branislav Líška
(4/2005, Topic ) - Care for patients after myocardial revascularization therapy in general practitioner`s office
Prof. MUDr. Vasiľ Hricák, PhD., FESC
(6/2016, Review articles ) - Eozinofilná ezofagitída
MUDr. Vladimír Klinovský
(3/2018, Review articles ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - TREATMENT OF PATIENT WITH CONGESTIVE HEART FAILURE
prof. MUDr. Ján Murín, CSc.
(9/2006, Main topic ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Treatment of hypertension with a fixed combination. New evidence.
prof. MUDr. Miroslav Souček, CSc.
(10/2009, Review articles ) - Srdcové zlyhávanie 2016 (HFA/ESC) a 3. svetový kongres o akútnom srdcovom zlyhaní, Florencia, Taliansko, 21. – 24. mája 2016, 1. časť
doc. MUDr. Marian Sninčák, PhD., mim. prof.
(4/2016, Events ) - CHRONIC ISCHEMIC HEART DISEASE – STABLE ANGINA: CURRENT DIAGNOSTIC AND TREATMENT POSSIBILITIES
MUDr. Stanislav Juhás, CSc.
(11/2007, Topic ) - Depressive disorders in general practitioners practice – part I.
MUDr. Peter Marko
(10/2009, General Medicine ) - Po 20 rokoch nový terapeutický princíp v liečbe ischemickej choroby srdca
prof. MUDr. Viliam Bada, CSc.
(11/2006, Spectrum ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic )
- THE PHARMACOTHERAPY OF DEPRESSION
doc. MUDr. Ján Praško, CSc., , MUDr. Hana Prašková
(5/2006, Review articles ) - Current trends in the cognitive pharmacotherapy of Alzheimer´s disease
MUDr. Roman Jirák, CSc.
(2/2002, Review articles ) - PHARMACOLOGICAL INFLUENCE ON CRAVING
MUDr. Jela Hrnčiarová
(6/2004, Review articles ) - Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles ) - Combined therapy by Alzheimer´s disease
MUDr. Elena Žigová
(1/2013, Original articles & case reports ) - Intracranial bleeding associated with selective serotonin reuptake inhibitor paroxetine and coadministration with ibuprofen
prof. MUDr. Alexandra Žourková, CSc.
(5–6/2010, Original articles & case reports ) - ANTIDEPRESSANT AGENTS AND ARCHITECTURE OF SLEEP IN MAJOR DEPRESSION
MUDr. Michal Maršálek, CSc.
(3/2005, Review articles )
- Monitoring of the efficacy of novel oral anticoagulants
MUDr. Aleš Tomek, Mgr. Adriana Ruzsiková, MUDr. Marta Zvarová, doc. MUDr. Robert Mikulík, Ph.D.
(3/2014, Main topic ) - Pharmacological profile of Cymbalta
doc. MUDr. Edvard Ehler, CSc.
(3/2014, Pharmacotherapy ) - Farmakoterapie pokročilé Parkinsonovy nemoci
doc. MUDr. Petr Kaňovský, CSc., MUDr. Igor Nestrašil, MUDr. Martin Nevrlý, MUDr. Pavel Ressner
(2/2006, Review articles ) - Současné trendy v kognitivní farmakoterapii Alzheimerovy choroby
MUDr. Roman Jirák, CSc.
(2/2002, From the boundary of neurology ) - New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - Amyotrophic lateral sclerosis
MUDr. Eva Vlčková, Ph.D.
(6/2016, Main topic ) - Treatment of Parkinson’s disease
prof. MUDr. Ivan Rektor, CSc.
(6/2009, Main topic ) - Diabetic Neuropathy – Neurologist Perspective
MUDr. Tomáš Nedělka, doc. MUDr. Martin Bojar, CSc., MUDr. Radim Mazanec, Ph.D.
(6/2009, Review articles ) - Treating Alzheimer’s disease and related neurodegenerative dementias
doc. MUDr. Roman Jirák, CSc.
(6/2009, From the boundary of neurology ) - Deliberation about diagnostic overlaps of pregabalin treatment
MUDr. Pavel Dohnal
(4/2015, Case reports ) - Doporučená léčba po prodělané cévní mozkové příhodě
doc. MUDr. Zbyněk Kalita, CSc.
(6/2002, Review articles ) - Diagnostika a terapie Alzheimerovy choroby.
doc. MUDr. Roman Jirák, CSc.
(4/2008, Review articles ) - Léčba diabetické polyneuropatie
MUDr. Helena Vondrová, CSc.
(4/2008, Review articles )
- Hereditárna pankreatitída u 17-ročného pacienta
MUDr. Iveta Čierna, PhD., MUDr. Vladimír Cingel
(3/2011, Case reports ) - Homozygous familial hypercholesterolemia and its treatment, cholesterol screening in children in Slovakia
MUDr. Pavol Šimurka, PhD., MUDr. Martin Matejka, PhD., MUDr. Jana Malinová
(2/2016, Review articles )
- COMBINATION DRUG THERAPY IN MEN WITH LOWER URINARY TRACT SYMPTOMS: CONTEMPORARY STATUS
doc. MUDr. Jozef Marenčák, PhD.
(5-6/2007, Review articles )
- Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Systemic treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(3/2013, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - DNA repair and its reference to resistance to anticancer therapy
doc. MUDr. Mária Wagnerová, CSc., MUDr. Martina Čižmáriková, PhD., prof. MUDr. Anton Kohút, DrSc.,, prof. MUDr. Ladislav Mirossay, DrSc.
(4/2007, Review articles ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Metastatic colorectal cancer – results of treatment of the primary tumor localization
MUDr. Vanda Ušáková, PhD.
(2/2017, Review articles ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Topotecan in the treatment of recurrent ovarian carcinoma – the retrospective analysis
doc. MUDr. Jozef Mardiak, CSc., MUDr. Jozef Šufliarsky, MUDr. Oliver Sadovský, CSc., MUDr. Tomáš Minarik, MUDr. Michaela Kubíčková, MUDr. Tibor Lengyel, MUDr. Bohuslav Nižňanský
(6/2009, Original articles & case reports ) - Polycythemia vera – treatment options and today‘s practice
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(4/2019, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Can we expect „ A new era“ in melanoma?
MUDr. Zuzana Hlavatá
(5/2011, Review articles ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - Sorafenib and hepatocellular carcinoma
MUDr. Iveta Andrezálová Vochyanová
(1/2014, Drugs & drug classes ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Postavenie inhíbitorov aromatázy v adjuvantnej liečbe potmenopauzálnych žien s hormonálne pozitívnym karcinómom prsníka
MUDr. Jana Obertová
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Nilotinib – inhibítor tyrozínkinázy na liečbu chronickej myelocytovej leukémie (CML)
doc. PharmDr. Juraj Sýkora, CSc.
(2/2009, Drugs & drug classes ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Správy z podujatia ASCO Chicago 2015
(4/2015, Events ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Current possibilities of immunotherapy in the treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(4/2016, Main topic ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - Chemoterapy of advanced gastric cancer – do we need a new drug?
MUDr. Tomáš Šálek
(5/2013, Drugs & drug classes ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - Optimization of treatment of colorectal cancer
MUDr. Iveta Andrezálová Vochyanová
(5/2015, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - Selected epidemiological aspects of chronic lymphocytic leukaemia in Slovakia: results from the cross-sectional study
MUDr. Eva Mikušková, PhD., MUDr. Elena Marušáková, MBA, doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Emília Flochová, PhD., MUDr. Tomáš Guman, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Juraj Chudej, PhD., MUDr. Jana Jurkovičová, Prof. MUDr. Eva Králíková, CSc., MUDr. Miroslav Šimek, PhD., MUDr. Natália Štecová, MVDr. Martina Vulganová
(1/2020, Original articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Nonopioid analgesics and adjuvants in treatment of cancer pain
MUDr. Miroslav Ferenčík
(1/2017, Main topic ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Clinical experience with successful ruxolitinib treatment in a patient diagnosed with polycythemia vera
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(S2/2020, Case reports ) - Experience with exemestane in daily practise
MUDr. Jana Obertová, MUDr. Ivana Zigová
(3/2009, Original articles & case reports ) - Treatment of advance basal cell carcinoma vismodegib
MUDr. Slavomír Urbanček, PhD.
(2/2016, Drugs & drug classes ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - ASCO 2008, SPRÁVA Z MEDZINÁRODNÉHO STRETNUTIA ONKOLÓGOV
MUDr. Marcela Tkáčová
(4/2008, Events ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )
- NOVÉ ANTITROMBOTICKÉ LÉKY
MUDr. Jan Novotný, Ph.D.
(1/2007, clearly ) - EFFECTIVITY AND SAFETY OF COXIBS
doc. MUDr. Jozef Lukáč, CSc., MUDr. Oľga Lukáčová, CSc.
(3-4/2007, clearly ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly ) - NEW POSSIBILITIES OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AND TREATMENT FOR THE KNEE AND HIP ARTHROPLASTY IN ORTHOPEDIC SURGERY
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Daniela Kotuličová
(4/2008, Review articles )
- Ketamin in pain treatment
MUDr. Darina Hasarová
(1/2011, News in pharmacotherapy )
- Nové liečivá v EÚ registrované v roku 2011 (III.)
PharmDr. Peter Stanko
(3/2012, New drugs ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Huperzine A and other natural substances in treating Alzheimer's disease
PharmDr. Jan Martin, Mgr. Zuzana Kršková, doc. RNDr. Jaroslav Dušek, CSc.
(2/2011, Phytotherapy )
- Apixaban – a new oral anticoagulant
prof. MUDr. Peter Kubisz, DrSc., doc. MUDr. Ján Staško, PhD., mim. prof., MUDr. Zuzana Jedináková
(1/2014, Drugs & drug classes ) - Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles ) - Leech therapy in clinical practice
MUDr. Marek Čambal, PhD., RNDr. Milan Kozánek, CSc., doc. MUDr. Pavel Zonča, PhD.
(1-2/2012, Review articles ) - Endothelial function in experimental hypertension
RNDr. Angelika Púzserová, PhD., RNDr. Iveta Bernátová, DrSc.
(1-2/2012, Original articles & Case reports ) - Rivaroxaban (XARELTO) – an orally administered anticoagulant for thromboprophylaxis in orthopedic surgery
doc. MUDr. Otto Mayer, CSc.
(3/2010, Drugs & drug classes ) - Hemophilia A and risk of inhibitor development – what changed the SIPPET study?
Prof. MUDr. Ján Staško, PhD., MUDr. Juraj Sokol, PhD., MUDr. Lucia Stančiaková, PhD., MUDr. Tomáš Šimurda, MUDr. Pavol Hollý, PhD, prof. MUDr. Peter Kubisz, DrSc.
(3-4/2017, Main topic ) - Acquired hemophilia A
Doc. MUDr. Mária Hulíková, PhD.
(3-4/2017, Main topic ) - Apixaban has been available for the treatment of venous thromboembolic disease for more than two years
Doc. MUDr. Debora Karetová, CSc., prof. MUDr. Jan Bultas, CSc.
(3-4/2017, Drugs & drug classes ) - New possibilities in treatment of venous thromboembolism – EINSTEIN clinical program
prof. MUDr. Viera Štvrtinová, PhD.
(4/2011, Drugs & drug classes ) - Platelet function in relation to the vessel wall
MUDr. Peter Chudý, PhD., MUDr. Daniela Kotuličová, MUDr. Juraj Chudej, PhD., prof. MUDr. Peter Kubisz, DrSc.
(1/2011, Main topic ) - Hemostasis and pregnancy complications
doc. MUDr. Mária Hulíková, PhD.
(2/2016, Main topic )